PJT Partners advised Alkegen's lenders on a restructuring that eliminates about $3.1 billion of debt, after a 2024 refinancing bought time but never fixed the leverage problem.
Alkegen, a global specialty materials manufacturer, specializes in highly engineered insulation, filtration, and fire protection products for industrial and advanced manufacturing applications. Recently, PJT Partners' Restructuring & Special Situations Group advised Alkegen's lenders on a restructuring designed to eliminate about $3.1 billion in debt. The transaction also included $315 million in new-money debtor-in-possession (DIP) financing to support operations, with ownership of the reorganized company shifting to institutional investors.4
Taking a step back, Alkegen reached the point of necessary restructuring because of excessive leverage, weaker industrial demand, and competitive pressures. The company's growing debt exposure can be traced in part to 2021, when Unifrax acquired Lydall to expand into filtration technologies and advanced materials to fuel further growth.1 The combined company was renamed Alkegen in January 2022. The acquisition was supported by about $1.2 billion in committed debt financing, along with additional cash and equity commitments from investors.2 Alkegen also expanded further in 2022, including acquiring a controlling stake in Luyang, a Chinese specialty materials manufacturer.
These acquisitions increased Alkegen's debt exposure while expanding its presence in new markets. The company relied on future operating improvements to meet its obligations, so weaker performance could become much more concerning. It also increased its exposure to cyclical industrial markets, as both businesses served customers whose spending depended heavily on manufacturing activity. This created a vulnerability, as Alkegen's financial obligations were relatively fixed, but the cash flows supporting them were not.
Unfortunately, industrial demand weakened, with higher interest rates and competitive pressures affecting markets such as steel, construction, and automotive manufacturing. These markets were important to Alkegen, and weaker demand made it increasingly difficult to service its debt. Competition from Chinese manufacturers also pressured pricing, while certain growth initiatives did not develop as quickly as management had anticipated.
This brings us to Alkegen's first major attempt to address its debt problem without entering Chapter 11. In September 2024, the company completed a liability management exercise that refinanced substantial portions of its debt and extended key maturities from 2025 to 2029. The transaction also reorganized creditor priorities, including a new first-out revolving credit facility, while providing additional liquidity.3 It allowed certain interest payments to be made through payment-in-kind (PIK) interest, adding unpaid interest to outstanding principal rather than requiring an immediate cash payment. This helped preserve liquidity while management worked to improve operating performance.
On paper, Alkegen was in a better position if all went well. The company had more time before its debt matured, additional liquidity, and an opportunity to improve its operations. However, this attempt did not meaningfully reduce its overall debt burden. Alkegen had addressed an immediate liquidity and maturity problem, but its longer-term financial position still depended on operating improvements that had yet to materialize.
By early 2026, the limitations of the earlier refinancing were becoming increasingly clear. Operating performance remained under pressure, the company continued to carry a substantial debt burden, and its ability to defer certain interest payments was approaching expiration in September. Without improving cash flow or meaningfully reducing debt, Alkegen faced increasingly difficult financial obligations. The 2024 refinancing bought time, but it did not solve the underlying leverage problem.
This was the turning point for Alkegen. Rather than pursuing another temporary solution, the company began negotiating a more comprehensive restructuring with its lenders. PJT Partners' RSSG team advised an ad hoc group of first-lien and second-lien creditors alongside Davis Polk & Wardwell, representing their interests throughout the restructuring process.45
In July 2026, Alkegen announced a restructuring support agreement and subsequently entered a prepackaged Chapter 11 process. The plan aimed to reduce total debt from about $3.5 billion to $400 million while allowing the company to keep operating.4 Under the reorganization, existing first-lien creditors were positioned to receive substantially all of the new equity, shifting ownership away from existing shareholders.5 The bankruptcy court confirmed the plan in September 2026.6
Rather than liquidating its assets under Chapter 7, Alkegen pursued a restructuring that preserved the value of its operating business. This gave creditors an opportunity to participate in the reorganized company while allowing Alkegen to move forward with significantly less debt. To me, this is an important distinction: the underlying business could continue operating, but the capital structure supporting it needed to change.
As a student at Emory becoming more familiar with capital structure solutions, Chapter 11 processes, and out-of-court alternatives, my biggest takeaway is the difference between fixing liquidity and fixing solvency. The 2024 refinancing bought Alkegen time and improved its short-term flexibility, but it did little to permanently reduce its debt burden. When operating improvements did not materialize as expected, the company needed a more comprehensive solution.
What I find especially interesting about PJT's involvement is the creditor-side perspective. The restructuring wasn't simply about eliminating debt; it also involved negotiating how value would be distributed among creditors and other stakeholders while preserving the underlying business. As I continue learning more about restructuring, this combination of financial analysis, negotiation, and creative capital structure solutions is what makes the field so interesting to me.
- "Clearlake Capital-Backed Unifrax Completes Acquisition of Lydall," Clearlake Capital, October 8, 2021. clearlake.com ↗
- Lydall, Inc., Preliminary Merger Proxy Statement, U.S. Securities and Exchange Commission, 2021. sec.gov ↗
- "Alkegen $2.125 Billion Financing and Comprehensive Liability Management Exercise," Davis Polk & Wardwell, 2024. davispolk.com ↗
- "Alkegen Enters Into Restructuring Support Agreement to Eliminate $3.1 Billion of Debt," Alkegen, July 20, 2026. alkegen.com ↗
- "Alkegen Prearranged Chapter 11 Filing and Restructuring Support Agreement," Davis Polk & Wardwell, August 2026. davispolk.com ↗
- "Alkegen Announces Confirmation of Plan of Reorganization," Alkegen, September 3, 2026. alkegen.com ↗
Get the next story by email.Free. Sent when a new piece is out.